2025 annual financial data
Monte Rosa Therapeutics 2025 Operating margin
Monte Rosa Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -43.83%.
Operating income was -54,208,000 USD and net income was -38,626,000 USD.
Operating cash flow was -22,798,000 USD.
Get free Monte Rosa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 123,672,000 USD
- Operating income
- -54,208,000 USD
- Net income
- -38,626,000 USD
- Operating cash flow
- -22,798,000 USD